S
SGMO
Sangamo Therapeutics Inc
0.53
0.00+0.06%Opening14:36 09/04 EDT
OPEN/PREV CLOSE0.5192/0.5340
TODAY RANGE0.4700-0.5423
VOL8.19M
MARKET CAP161.20M
52 WEEK RANGE0.4111-3.179
AVG VOL (3M)5.83M
% TURNOVER2.71%
TURNOVER--
P/E (TTM)-1.8800
% RANGE13.54%
EPS(TTM)-0.2842
P/E(FORWARD)-1.6265
P/B7.43
BVPS0.0719
DIVIDEND--
P/S1.967
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP157.74M
SHARES OUTSTANDING301.71M
NEXT EARNINGS11/10-11/14
FREE FLOAT295.22M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·6h ago
Sangamo presents detailed data from STAAR study
NASDAQ·08/14 16:00
What Makes Sangamo (SGMO) a New Buy Stock
TipRanks·08/12 00:36
Sangamo Biosciences: Cautious Optimism in Earnings Call
TipRanks·08/11 10:26
Sangamo Biosciences: Strategic Positioning and Growth Potential Drive Buy Rating
TipRanks·08/08 08:47
Barclays Remains a Buy on Sangamo Biosciences (SGMO)
TipRanks·08/08 04:47
Sangamo Therapeutics Reports Strong Q2 2025 Results
Reuters·08/07 20:19
Sangamo Therapeutics Q2 revenue misses estimates
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.